These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Evaluation of functional outcome measures after fampridine treatment in patients with multiple sclerosis - An interventional follow-up study. Skov CD; Sørensen CB; Thorning M; Lambertsen KL; Frich LH; Jensen HB; Holsgaard-Larsen A; Nielsen HH Mult Scler Relat Disord; 2022 Oct; 66():104034. PubMed ID: 35843140 [TBL] [Abstract][Full Text] [Related]
4. Improving our understanding of the most important items of the Multiple Sclerosis Walking Scale-12 indicating mobility dysfunction: Secondary results from a RIMS multicenter study. Kalron A; Ehling R; Baert I; Smedal T; Rasova K; Heric-Mansrud A; Elorriage I; Nedeljkovic U; Tachino A; Gargul L; Gusowski K; Cattaneo D; Borgers S; Hebert J; Dalgas U; Feys P Mult Scler Relat Disord; 2020 Nov; 46():102511. PubMed ID: 32949848 [TBL] [Abstract][Full Text] [Related]
5. Performed and perceived walking ability in relation to the Expanded Disability Status Scale in persons with multiple sclerosis. Langeskov-Christensen D; Feys P; Baert I; Riemenschneider M; Stenager E; Dalgas U J Neurol Sci; 2017 Nov; 382():131-136. PubMed ID: 29111007 [TBL] [Abstract][Full Text] [Related]
6. Responsiveness and clinically meaningful changes for the Persian versions of the multiple sclerosis walking scale-12 and the modified fatigue impact scale following balance and gait rehabilitation in people with multiple sclerosis. Monjezi S; Molhemi F; Shaterzadeh Yazdi MJ; Salehi R; Mehravar M; Kashipazha D Physiother Theory Pract; 2022 Mar; 38(3):464-470. PubMed ID: 32431220 [No Abstract] [Full Text] [Related]
7. Responsiveness of Persian 12-Item multiple sclerosis walking scale: a replication study. Naghdi S; Ansari NN; Haghparast A; Nakhostin-Ansari A; Khalifeloo M; Biglar M; Lotfi R; Hasson S BMC Res Notes; 2023 Apr; 16(1):45. PubMed ID: 37016445 [TBL] [Abstract][Full Text] [Related]
8. Comparison of patient-reported outcomes of physical activity and accelerometry in people with multiple sclerosis and ambulatory impairment: A cross-sectional study. Wanitschek A; Seebacher B; Muehlbacher A; Brenneis C; Ehling R Mult Scler Relat Disord; 2024 May; 85():105532. PubMed ID: 38452648 [TBL] [Abstract][Full Text] [Related]
9. Translation and validation of the multiple sclerosis walking scale 12 for the German population - the MSWS-12/D. Chorschew A; Kesgin F; Bellmann-Strobl J; Flachenecker P; Schiffmann I; Rosenthal F; Althoff P; Drebinger D; Arsenova R; Rasche L; Dorsch EM; Heesen C; Paul F; Stellmann JP; Schmitz-Hübsch T Health Qual Life Outcomes; 2023 Oct; 21(1):110. PubMed ID: 37814258 [TBL] [Abstract][Full Text] [Related]
10. Fear of falling, not falls, impacts leisure-time physical activity in people with multiple sclerosis. Kalron A; Aloni R; Givon U; Menascu S Gait Posture; 2018 Sep; 65():33-38. PubMed ID: 30558943 [TBL] [Abstract][Full Text] [Related]
11. Within-day variability on short and long walking tests in persons with multiple sclerosis. Feys P; Bibby B; Romberg A; Santoyo C; Gebara B; de Noordhout BM; Knuts K; Bethoux F; Skjerbæk A; Jensen E; Baert I; Vaney C; de Groot V; Dalgas U J Neurol Sci; 2014 Mar; 338(1-2):183-7. PubMed ID: 24439144 [TBL] [Abstract][Full Text] [Related]
12. Prognosis of walking function in multiple sclerosis supported by gait pattern analysis. Zörner B; Hostettler P; Meyer C; Killeen T; Gut P; Linnebank M; Weller M; Straumann D; Filli L Mult Scler Relat Disord; 2022 Jul; 63():103802. PubMed ID: 35487034 [TBL] [Abstract][Full Text] [Related]
13. Monitoring long-term efficacy of fampridine in gait-impaired patients with multiple sclerosis. Filli L; Zörner B; Kapitza S; Reuter K; Lörincz L; Weller D; Sutter T; Killeen T; Gruber P; Petersen JA; Weller M; Linnebank M Neurology; 2017 Feb; 88(9):832-841. PubMed ID: 28148629 [TBL] [Abstract][Full Text] [Related]
14. Japanese translation and validation of the 12-item Multiple Sclerosis Walking Scale version 2. Miyazaki Y; Niino M; Takahashi E; Sato C; Naganuma R; Amino I; Akimoto S; Minami N; Kikuchi S Mult Scler Relat Disord; 2024 Sep; 89():105768. PubMed ID: 39003823 [TBL] [Abstract][Full Text] [Related]
15. Timed 25-foot walk: direct evidence that improving 20% or greater is clinically meaningful in MS. Hobart J; Blight AR; Goodman A; Lynn F; Putzki N Neurology; 2013 Apr; 80(16):1509-17. PubMed ID: 23535489 [TBL] [Abstract][Full Text] [Related]
16. Maximum walking speed in multiple sclerosis assessed with visual perceptive computing. Grobelny A; Behrens JR; Mertens S; Otte K; Mansow-Model S; Krüger T; Gusho E; Bellmann-Strobl J; Paul F; Brandt AU; Schmitz-Hübsch T PLoS One; 2017; 12(12):e0189281. PubMed ID: 29244874 [TBL] [Abstract][Full Text] [Related]
17. Prevalence and determinants of falls in persons with multiple sclerosis without a clinical disability. Abasıyanık Z; Kahraman T; Ertekin Ö; Baba C; Özakbaş S Mult Scler Relat Disord; 2021 Apr; 49():102771. PubMed ID: 33493789 [TBL] [Abstract][Full Text] [Related]
18. Ecological validity of walking capacity tests following rehabilitation in people with multiple sclerosis. Ehling R; Bsteh G; Muehlbacher A; Hermann K; Brenneis C PLoS One; 2019; 14(8):e0220613. PubMed ID: 31369622 [TBL] [Abstract][Full Text] [Related]
19. Dynamometer-based measure of spasticity confirms limited association between plantarflexor spasticity and walking function in persons with multiple sclerosis. Kremer TR; Van Dillen LR; Wagner JM J Rehabil Res Dev; 2014; 51(6):975-84. PubMed ID: 25356797 [TBL] [Abstract][Full Text] [Related]
20. Exercise as a therapy for improvement of walking ability in adults with multiple sclerosis: a meta-analysis. Pearson M; Dieberg G; Smart N Arch Phys Med Rehabil; 2015 Jul; 96(7):1339-1348.e7. PubMed ID: 25712347 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]